1-[(3-氯苯基)甲基]-5-氧代-2-吡咯烷羧酸 | 103201-07-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 1-[(3-氯苯基)甲基]-5-氧代-2-吡咯烷羧酸
• 英文名称: 1-[(3-Chlorophenyl)methyl]-5-oxo-2-pyrrolidinecarboxylic acid
• 英文别名: 1-[(3-chlorophenyl)methyl]-5-oxopyrrolidine-2-carboxylic acid；(+/-)-1-<(3-chlorophenyl)methyl>-5-oxoproline；(+/-)-1-[(3-Chlorophenyl)methyl]-5-oxo-2-pyrrolidinecarboxylic acid；1-(3-Chlorobenzyl)-5-oxopyrrolidine-2-carboxylic acid
• CAS: 103201-07-6
• 化学式: C₁₂H₁₂ClNO₃
• 分子量: 253.685
• InChiKey: HTTLIOSKZPIJHB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  57.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-[(3-氯苯基)甲基]-5-氧代-2-吡咯烷羧酸 在 三氯化铝 、 氯化亚砜 作用下， 以51%的产率得到(+/-)-7-chloro-1,10a-dihydropyrrolo<1,2-b>isoquinoline-3,10(2H,5H)-dione
  参考文献：
  名称：

  由吡咯并[1,2- b ]异喹啉合成新型1,2,3,4-四氢苯并[ c ] -1,5-萘啶

  摘要：

  1,2,3,4-四氢苯并[ c ] -1,5-萘啶（5a）是通过涉及（±）-（Z）-1,10a-二氢吡咯并[1,2- b ]异喹啉-3,10（2 H，5 H）-二酮肟制得1,4-二氢苯并[ c ] -1,5-萘啶-2（3 H）-一，还原为5a。用5a观察到的拟胆碱活性促使其他类似物的合成和生物学评估。

  DOI：

  10.1002/jhet.5570240609
• 作为产物：
  描述：

  5-氧代吡咯烷-2-羧酸乙酯 在 sodium hydroxide 、 水 、 sodium hydride 作用下， 反应 4.5h， 生成 1-[(3-氯苯基)甲基]-5-氧代-2-吡咯烷羧酸
  参考文献：
  名称：

  A novel synthesis of 1,4-dihydrobenzo[c]-1,5-naphthyridin-2(3H)-ones from pyrrolo[1,2-b]isoquinolines

  摘要：

  DOI：

  10.1021/jo00369a026

文献信息

• Benzoc[c]-1,5-naphthyridines and related compounds as memory enhancing
  申请人：Hoechst-Roussel Pharmaceuticals Inc.

  公开号：US04742061A1

  公开（公告）日：1988-05-03

  There are disclosed novel compounds of the formula ##STR1## where m is 1 or 2; each X is independently H, halogen, loweralkyl, loweralkoxy, --CF.sub.3, or --OH; R is H, loweralkyl, chloroloweralkyl, bromoloweralkyl, iodoloweralkyl, aminoloweralkyl, loweralkylaminoloweralkyl, diloweralkylaminoloweralkyl, arylloweralkyl, diarylloweralkyl, thienylloweralkyl, furylloweralkyl, loweralkanoyl, chloroloweralkanoyl, bromoloweralkanoyl, iodoloweralkanoyl, aminoloweralkanoyl, loweralkylaminoloweralkanoyl, diloweralkylaminoloweralkanoyl, aroyl, arylloweralkanoyl or diarylloweralkanoyl, thienylloweralkanoyl, furylloweralkanoyl; and R.sub.1 is .dbd.O, ##STR2## or --NR.sub.2 R.sub.3, R.sub.2 and R.sub.3 being independently H or loweralkyl, or taken together with the nitrogen atom to which they are attached constituting ##STR3## R.sub.4 in turn being H, loweralkyl, hydroxyloweralkyl, aryl, arylloweralkyl or diarylloweralkyl, with the proviso that when R.sub.1 is --NR.sub.2 R.sub.3, R is nonexistent, that when R.sub.1 is .dbd.O, R is not an acyl group and that when R.sub.1 is ##STR4## R is not chloroloweralkyl, bromoloweralkyl or iodoloweralkyl; or pharmaceutically acceptable acid addition salts thereof, which are useful for enhancing memory.

  公开了一种新颖的化合物，其化学式为##STR1##其中m为1或2；每个X独立地为H、卤素、较低烷基、较低烷氧基、--CF.sub.3或--OH；R为H、较低烷基、氯代较低烷基、溴代较低烷基、碘代较低烷基、氨基较低烷基、较低烷基氨基较低烷基、二较低烷基氨基较低烷基、芳基较低烷基、二芳基较低烷基、噻吩基较低烷基、呋喃基较低烷基、较低烷酰基、氯代较低烷酰基、溴代较低烷酰基、碘代较低烷酰基、氨基较低烷酰基、较低烷基氨基较低烷酰基、二较低烷基氨基较低烷酰基、芳酰基、芳基较低烷酰基或二芳基较低烷酰基、噻吩基较低烷酰基、呋喃基较低烷酰基；而R.sub.1为.dbd.O、##STR2##或--NR.sub.2 R.sub.3，其中R.sub.2和R.sub.3独立地为H或较低烷基，或与它们连接的氮原子一起构成##STR3##R.sub.4又为H、较低烷基、羟基较低烷基、芳基、芳基较低烷基或二芳基较低烷基，但有一个限制条件，即当R.sub.1为--NR.sub.2 R.sub.3时，R不存在，当R.sub.1为.dbd.O时，R不是酰基，当R.sub.1为##STR4##时，R不是氯代较低烷基、溴代较低烷基或碘代较低烷基；或其药学上可接受的酸盐，用于增强记忆。
• Benzo(c)-1,5-naphthyridines useful for treating a patient having drug
  申请人：Hoechst-Roussel Pharmaceuticals Inc.

  公开号：US04652567A1

  公开（公告）日：1987-03-24

  There are disclosed novel compounds of the formula ##STR1## where X is H, halogen, loweralkyl, loweralkoxy, --CF.sub.3, or --OH; R is H, loweralkyl, arylloweralkyl, diarylloweralkyl, loweralkanoyl, arylloweralkanoyl or diarylloweralkanoyl; and R.sub.1 is H.sub.2, O or --NR.sub.2 R.sub.3, R.sub.2 and R.sub.3 being independently H or loweralkyl, or taken together with the nitrogen atom to which they are attached constitute ##STR2## R.sub.4 in turn being H, loweralkyl, hydroxyloweralkyl, aryl, arylloweralkyl or diarylloweralkyl or pharmaceutically acceptable acid addition salts thereof, which are useful for enhancing memory.

  揭示了一种新颖的化合物，其化学式为##STR1##其中X为H、卤素、较低的烷基、较低的烷氧基、--CF.sub.3或--OH；R为H、较低的烷基、芳基较低的烷基、二芳基较低的烷基、较低的烷酰基、芳基较低的烷酰基或二芳基较低的烷酰基；R.sub.1为H.sub.2、O或--NR.sub.2 R.sub.3，其中R.sub.2和R.sub.3独立地为H或较低的烷基，或者与它们连接的氮原子一起构成##STR2##R.sub.4又为H、较低的烷基、羟基较低的烷基、芳基、芳基较低的烷基或二芳基较低的烷基，或其药用可接受的酸盐，用于增强记忆。
• [EN] ANTIVIRAL COMPOUNDS<br/>[FR] COMPOSÉS ANTIVIRAUX
  申请人：HAPLOGEN GMBH

  公开号：WO2018050631A1

  公开（公告）日：2018-03-22

  The present invention relates to novel compounds of general formula (I) wherein the groups X, and R1 to R4 have the meanings given in the description and claims, process for preparing these compounds and their use as for treating, preventing or ameliorating viral infections and their use for treating, preventing or ameliorating diseases which are associated with PLA2G16.

  本发明涉及一般式（I）的新化合物，其中X和R1至R4基团的含义如描述和索赔中所述，制备这些化合物的方法以及它们作为治疗、预防或改善病毒感染的用途，以及用于治疗、预防或改善与PLA2G16相关的疾病的用途。
• [EN] CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS<br/>[FR] COMPOSÉS DE CARBOXAMIDE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE LA CALPAÏNE
  申请人：ABBOTT GMBH & CO KG

  公开号：WO2010128102A1

  公开（公告）日：2010-11-11

  The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. The carboxamide compounds are compounds of the general formula (I) in which R1, R2, R3a, R3b, R4, Q, Y, A and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula (Ia) and (Ib) in which R1, r, R2b, R3a, R3b, R4, Y and X have the meanings mentioned in the claims, including the tautomers thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein Y is a moiety CH2-CH2, CH2-CH2-CH2, N(Ry#)-CH2, N(Ry#)-CH2-CH2 or CH=CH-CH=, each optionally having 1 or 2 H-atoms replaced with identical or different radicals Ry, wherein Ry and Ry# have the meanings mentioned in the claims.

  本发明涉及新型羧酰胺化合物及其用于制备药物的用途。这些羧酰胺化合物是钙蛋白酶（依赖于钙的半胱氨酸蛋白酶）的抑制剂。因此，该发明还涉及利用这些羧酰胺化合物治疗与升高的钙蛋白酶活性相关的疾病。这些羧酰胺化合物是通式（I）的化合物，其中R1、R2、R3a、R3b、R4、Q、Y、A和X具有权利要求和说明中提及的含义，以及它们的互变异构体和药用盐。特别地，这些化合物具有通式（Ia）和（Ib），其中R1、r、R2b、R3a、R3b、R4、Y和X具有权利要求中提及的含义，包括它们的互变异构体和药用盐。在这些化合物中，首选Y是一个基团CH2-CH2、CH2-CH2-CH2、N(Ry#)-CH2、N(Ry#)-CH2-CH2或CH=CH-CH=，每个基团可选择地用1或2个氢原子替换为相同或不同的基团Ry，其中Ry和Ry#具有权利要求中提到的含义。
• Dihydropyrrolo[1,2-b]isoquinolinedione oximes
  申请人：Hoechst-Roussel Pharmaceuticals Inc.

  公开号：US04670562A1

  公开（公告）日：1987-06-02

  There is disclosed novel compounds of the formula ##STR1## where X is H, halogen, loweralkyl, loweralkoxy, -CF.sub.3, or -OH; R is H, loweralkyl, arylloweralkyl, diarylloweralkyl, loweralkanoyl, arylloweralkanoyl or diarylloweralkanoyl; and R.sub.1 is H.sub.2, O or --NR.sub.2 R.sub.3, R.sub.2 and R.sub.3 being independently H or loweralkyl, or taken together with the nitrogen atom to which they are attached constitute ##STR2## R.sub.4 in turn being H, loweralkyl, hydroxyloweralkyl, aryl, arylloweralkyl or diarylloweralkyl or pharmaceutically acceptable acid addition salts thereof, which are useful for enchancing memory.

  公开了新型化合物的公式 ##STR1## 其中X为H、卤素、低烷基、低烷氧基、-CF.sub.3或-OH; R为H、低烷基、芳基低烷基、二芳基低烷基、低烷酰基、芳基低烷酰基或二芳基低烷酰基; R.sub.1为H.sub.2、O或--NR.sub.2 R.sub.3，其中R.sub.2和R.sub.3独立地为H或低烷基，或与它们连接的氮原子一起构成 ##STR2## R.sub.4则为H、低烷基、羟基低烷基、芳基、芳基低烷基或二芳基低烷基或其药学上可接受的酸盐，用于增强记忆。